Bosentan improves exercise capacity in adolescents and adults after Fontan operation: the TEMPO (Treatment With Endothelin Receptor Antagonist in Fontan Patients, a Randomized, Placebo-Controlled, Double-Blind Study Measuring Peak Oxygen Consumption
about
Current Therapy for Hypoplastic Left Heart Syndrome and Related Single Ventricle Lesions.Pulmonary Hypertension in Children.The Changing Landscape of Pulmonary Arterial Hypertension in the Adult with Congenital Heart Disease.The use of Macitentan in Fontan circulation: a case report.Differentiation of Impaired From Preserved Hemodynamics in Patients With Fontan Circulation Using Real-time Phase-velocity Cardiovascular Magnetic Resonance.Emerging Research Directions in Adult Congenital Heart Disease: A Report From an NHLBI/ACHA Working Group.Pulmonary vasodilator therapy in the failing Fontan circulation: rationale and efficacy.Assessing ST Segment Changes and Ischemia During Exercise Stress Testing in Patients with Hypoplastic Left Heart Syndrome and Fontan Palliation.Results of a phase I/II multi-center investigation of udenafil in adolescents after fontan palliation.Drug therapy in the prevention of failure of the Fontan circulation: a systematic review.Fontan Conversion: Literature Review and Lessons Learned Over 20 Years.Clinical Approaches to the Patient with a Failing Fontan Procedure.The Long-Term Management of Children and Adults with a Fontan Circulation: A Systematic Review and Survey of Current Practice in Australia and New Zealand.Clinical Phenotypes of Fontan Failure: Implications for Management.Diagnosis of occult diastolic dysfunction late after the Fontan procedure using a rapid volume expansion technique.Invited Commentary: The specialty of adult congenital heart diseaseThe Pulmonary Circulation in the Single Ventricle PatientD-optimal Design for Preparation and Optimization of Fast Dissolving Bosentan Nanosuspension.Efficacy of Bosentan in patients after Fontan procedures: a double-blind, randomized controlled trial.Where Is the "Optimal" Fontan Hemodynamics?Hemodynamic impact of pulmonary vasodilators on single ventricle physiology."Frontiers in Fontan failure: A summary of conference proceedings".Model-Based Comparison of the Normal and Fontan Circulatory Systems-Part III.Hemodynamics of Fontan Failure: The Role of Pulmonary Vascular Disease.Diagnosis, Evaluation and Treatment of Pulmonary Arterial Hypertension in Children.Management of Heart Failure in Adult Congenital Heart Disease
P2860
Q30244119-97579CF3-0E6A-4745-BBE8-CC6718325A62Q30248871-5E483CBD-4F56-46B6-A60B-39C4EF75AAEEQ33608215-13DA9648-C468-4C99-AC88-717F59178543Q33717010-CEF2A15B-CF69-4234-87A6-B8D8019D4965Q36323665-BD0820B0-227F-4839-97F2-1C644FA10EF7Q36841436-EE46FC07-B6DB-4B83-BC4C-7D4830132D01Q38671350-3366E219-B9AA-4A63-AFB6-6237EB5AEE35Q38685509-245EBC3E-C220-47F0-9EF3-3575836D8FBBQ38746984-AA46F274-2AC5-415C-8101-6DA91D8535EAQ38762647-4CF0FF21-9584-406F-95B4-F7336FE366DEQ38766334-86249231-CAA7-4CA9-947B-CCFA2C865FA1Q38784643-9968DDD3-78F6-45CD-9F7C-4F6B88D3E866Q38804287-1CFA72C7-FC42-4208-BD80-014E7DC8ED8DQ38844501-0A26047D-79E1-4318-B940-DFF172C2E8CAQ38903120-61CEFD1D-392D-43B7-A4D6-2D4C866F12D5Q38980748-637A8BA6-4648-4B60-B841-47040B3A202CQ41552536-DCBCBB9E-629F-443D-92F4-412FCF3CFEA2Q42012709-2CFBCB08-49E0-48DF-8605-30EC8C9453FAQ46460624-9010B1BD-FC4B-465A-961D-D003549744F8Q47098111-F5EC0897-CF7C-464D-BF94-7BA9D9717F8FQ47385953-5666F959-DC60-4618-BF1D-B48A8A7A58EFQ47663879-288A6E1F-A8D6-4277-BB5E-0096B09D270BQ47942365-AFBBDE2D-F3B2-4248-B420-CD21C7BD461EQ49791500-8532F253-9503-4A55-8F90-2355CF32E066Q55001904-43120774-26CC-450A-B6F1-5AE45EBB3EC0Q58732003-410EE98A-D488-4049-809C-F327ABE17D93
P2860
Bosentan improves exercise capacity in adolescents and adults after Fontan operation: the TEMPO (Treatment With Endothelin Receptor Antagonist in Fontan Patients, a Randomized, Placebo-Controlled, Double-Blind Study Measuring Peak Oxygen Consumption
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Bosentan improves exercise cap ...... suring Peak Oxygen Consumption
@en
type
label
Bosentan improves exercise cap ...... suring Peak Oxygen Consumption
@en
prefLabel
Bosentan improves exercise cap ...... suring Peak Oxygen Consumption
@en
P2093
P1433
P1476
Bosentan improves exercise cap ...... suring Peak Oxygen Consumption
@en
P2093
Anders Hebert
Annette S Jensen
Katarina Hanseus
Keld E Sørensen
Lars Idorn
Lars Søndergaard
Ulla R Mikkelsen
P304
P356
10.1161/CIRCULATIONAHA.113.008441
P407
P50
P577
2014-10-20T00:00:00Z